MedtechLedger currently links 21 FDA records to the applicant name Endotronix, Inc.. It includes 1 original PMA approval. 4 entries are PMA supplements. 16 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jun 20, 2024 to Oct 29, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Changes described in PMA records
The FDA record for P230040/S030 lists a normal 180-day track supplement with no user fee, dated October 29, 2026, for Endotronix, Inc.'s Cordella Pulmonary Artery Sensor System under product code MOM. The stated change is the addition of an alternate ethylene oxide (EO) gas sterilization facility, categorized as a location change affecting manufacturer, sterilizer, packager or supplier. Because the identifier links this to original PMA P230040, it is a supplement rather than a new approval of the whole system.
The record does not identify the new facility, its location, the sterilization cycle parameters, or any validation data. The stated purpose describes a manufacturing and sterilization-site addition only; it is not evidence of clinical safety or effectiveness of the device itself, and no such conclusion should be drawn from this notice.
FDA approval-order wording
addition of alternate Ethyle Oxide (EO) gas sterilization facility
Oct 29, 2026 · Normal 180 Day Track No User FeeThe FDA recorded decision OK30 on 2026-10-20 for P230040/S035, a 30-Day Notice supplement to the Cordella Pulmonary Artery Sensor System (CorPASS) held by Endotronix, Inc. The supplement falls under the process change category for manufacturer, sterilizer, packager or supplier. The stated scope is removal of a redundant inspection process of the Coil PCB subassemblies. The device is listed in the implantable hemodynamic system category under the Cardiovascular specialty with product code MOM.
This action covers a manufacturing process change for a named subassembly rather than a new approval of the whole CorPASS system. The source record does not describe the inspection method removed, the rationale for treating it as redundant, or any verification data supporting the change; those details would sit in the supplement submission, which is not included here. No clinical, efficacy or patient-selection conclusions follow from this record, and the source gives no information on current labeling or post-change performance.
FDA approval-order wording
removal of a redundant inspection process of the Coil PCB subassemblies
Oct 20, 2026 · 30-Day NoticeThe FDA recorded an approval decision on 2026-10-16 for supplement P230040/S031, submitted by Endotronix, Inc. for the Cordelia Pulmonary Artery Pressure Sensor System (CorPASS). The supplement is classified as a Real-Time Process submission with the reason Labeling Change - Indications/instructions/shelf life/tradename. The device falls under the implantable hemodynamic system category, cardiovascular specialty, product code MOM.
The recorded scope is limited to revisions to the Instructions for Use concerning recommendations for guidewire selections. This action amends labeling within the existing P230040 application rather than constituting a new approval of the whole system. The source record does not include the revised IFU text, the specific guidewire recommendations, or the original approval date, so the content of the change and any clinical implications remain unknown from this data alone.
FDA approval-order wording
revisions to the Instructions for Use (IFU) for the Cordelia Pulmonary Artery regarding recommendations for guidewire selections
Oct 16, 2026 · Real-Time ProcessThe FDA recorded a 30-Day Notice decision, OK30, dated 2026-10-14, for P230040/S034, a supplement to the Cordella Pulmonary Artery Sensor System (CorPASS) held by Endotronix, Inc. The supplement falls under the process change category covering manufacturer, sterilizer, packager or supplier, and the recorded statement describes automating an incoming functional inspection test method. The device is listed in the implantable hemodynamic system category within cardiovascular devices, product code MOM.
The notice addresses a manufacturing test-method change rather than a new approval of the CorPASS system as a whole; the underlying original approval and its clinical labeling are not restated here. The source record includes no documents, so the specific test method, affected manufacturing site and any inspection performance data remain unknown. Whether the automation alters inspection sensitivity or acceptance criteria cannot be determined from the available fields.
Readers should treat OK30 as the recorded decision on this supplement only. No clinical, efficacy or patient-selection conclusions follow from a process change of this kind, and none are asserted here.
FDA approval-order wording
automating an incoming functional inspection test method
Oct 14, 2026 · 30-Day NoticeThe FDA record for P230040/S033 lists a 30-Day Notice for the Cordella Pulmonary Artery Sensor System (CorPASS) under product code MOM, decided OK30 on 2026-09-25. The stated reason is a process change affecting manufacturer, sterilizer, packager or supplier. The listed change is that acceptance criteria for the Interrogation Inspection method were updated. The record does not specify which acceptance criteria changed, their prior or new values, or what the inspection covers.
The S033 identifier places this as a supplement to PMA P230040 rather than a new approval of the whole system. The stated purpose is a manufacturing process change; the record does not present it as evidence of safety or clinical effectiveness, and it adds no indication, trial or performance detail. Because the statement is brief, the scope of the revision stays unknown beyond the field label.
FDA approval-order wording
updated acceptance criteria to the Interrogation Inspection method
Sep 25, 2026 · 30-Day NoticeSubsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.